Lensar (LNSR) Gains from Sales and Divestitures (2019 - 2026)
Lensar (LNSR) reported Gains from Sales and Divestitures of $122000.0 for Q1 2026, down 29.07% year-over-year from $172000.0 in Q1 2025, and down 58.36% on a QoQ basis from $293000.0 in Q4 2025.
Lensar (LNSR) has 7 years of Gains from Sales and Divestitures data on file, last reported at $122000.0 in Q1 2026.
- Quarterly Gains from Sales and Divestitures fell 29.07% year-over-year to $122000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122000.0 (down 29.07% YoY) and the FY2025 annual result came in at $293000.0, up 22.59% from the prior year.
- Gains from Sales and Divestitures eased to $122000.0 in Q1 2026 per LNSR's latest filing, from $293000.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $704000.0 in Q4 2022 and bottomed at $84000.0 in Q1 2024.
- The 5-year median for Gains from Sales and Divestitures is $293000.0 (2025), against an average of $338941.2.
- The widest annual swing landed in 2022, when Gains from Sales and Divestitures surged 100109.64%; it then plunged 64.56% in 2024.
- Tracing LNSR's Gains from Sales and Divestitures over 5 years: stood at $704000.0 in 2022, then dropped by 12.5% to $616000.0 in 2023, then tumbled by 61.2% to $239000.0 in 2024, then grew by 22.59% to $293000.0 in 2025, then plunged by 58.36% to $122000.0 in 2026.
- Per Business Quant, the three latest LNSR Gains from Sales and Divestitures figures stand at $122000.0 (Q1 2026), $293000.0 (Q4 2025), and $293000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 293,000.00 |
| Dec 31, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 239,000.00 |
| Dec 31, 2024 | 239,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Sep 30, 2023 | 541,000.00 |
| Sep 30, 2023 | 541,000.00 |
| Jun 30, 2023 | 373,000.00 |
| Jun 30, 2023 | 373,000.00 |
| Mar 31, 2023 | 237,000.00 |
| Mar 31, 2023 | 237,000.00 |
| Dec 31, 2022 | 704,000.00 |
| Dec 31, 2022 | 704,000.00 |
| Sep 30, 2022 | 591,000.00 |
| Sep 30, 2022 | 591,000.00 |
| Jun 30, 2022 | 478,000.00 |
| Jun 30, 2022 | 478,000.00 |
| Mar 31, 2022 | 338,000.00 |
| Mar 31, 2022 | 338,000.00 |
| Dec 31, 2021 | 718,000.00 |
| Dec 31, 2021 | 718,000.00 |
| Sep 30, 2021 | 598.00 |
| Sep 30, 2021 | 598.00 |
| Jun 30, 2021 | 477.00 |
| Jun 30, 2021 | 477.00 |
| Mar 31, 2021 | 342.00 |
| Mar 31, 2021 | 342.00 |
| Dec 31, 2019 | 71,000.00 |
| Dec 31, 2019 | 71,000.00 |